Print
Administrative Support:
Jeff Wetmore,
Research Development and Proposal Services Coordinator
(405) 271-6751 x47385
Paula A. Meder,
Senior Administrative Manager
(405) 271-6593 x47271
Current Grants Awarded to Faculty
| Modulation of Host Defense by SP-A-TLR4 Interaction | |
| Shanjana Awasthi, Ph.D. - Principal Investigator | Agency - American Heart Association-Grant in Aid |
| Pancreatic cancer therapy with GRP receptor-targeted imageable diphenyl difluoroketone | |
| Vibhudutta Awasthi, Ph.D. - Principal Investigator | Agency - NCI-NIH (R03) |
| Biologic evaluation of liposome-encapsulated hemoglobin | |
| Vibhudutta Awasthi, Ph.D. - Principal Investigator | Agency - NHLBI-NIH (R01) |
| Effectiveness of an educational intervention on the caring behaviors and referral activities of community pharmacists for migraine patients | |
| Shane Desselle, Ph.D. - Principal Investigator | Agency - Merck & Company, Inc. |
| Evaluation of Merck's Headache School: A quasi-experimental phase 4 examination of effectiveness | |
| Shane Desselle, Ph.D. - Principal Investigator | Agency - Merck & Company, Inc. |
| The role of IL-6 in jet fuel irritant dermatitis | |
| Randle Gallucci, Ph.D. - Principal Investigator | Agency - NIOSH-NIH (R03) |
| The role of IL-6 in diabetic wound healing | |
| Randle Gallucci, Ph.D. - Principal Investigator | Agency - OCAST/Regular |
| Integration of diabetes self-management education in a patient-centered medical home | |
| Nancy Letassy, Pharm.D., CDE - Principal Investigator | Agency - American Association of Diabetes Educators |
| Study of the pharmacokinetics of daptomycin in children with renal disease | |
| Teresa Lewis, Pharm.D. - Principal Investigator | Agency - Cubist Pharmaceuticals Inc. |
| Bacteriophage control of DNA repair in streptococcus pyogenes | |
| W. Michael McShan, Ph.D. - Principal Investigator | Agency - NIAID-NIH (R15) |
| Mobile element SpyCIM1 Enhances Survival in S. pyogenes | |
| W. Michael McShan, Ph.D. - Principal Investigator | Agency - OCAST/Regular |
| Deep South Musculoskeletal CERTS (DSMC) | |
| Michael Miller, Ph.D. - OUHSC PI (Subcontractor) | Agency - Univ. of Alabama at Birmingham (DSMC) |
| Development of an antimicrobial peptide therapeutic for Pseudomonas infections | |
| H. Anne Pereira, Ph.D. - Principal Investigator | Agency - NIAID-NIH U01 |
| New therapeutics based on a natural antibiotic peptide | |
| H. Anne Pereira, Ph.D. - Principal Investigator | Agency - OCAST-OARS |
| CAP37 and ocular inflammation | |
| H. Anne Pereira, Ph.D. - Principal Investigator | Agency - NEI-NIH (R01) |
| New Drugs for Bad Bugs | |
| H. Anne Pereira, Ph.D. - Principal Investigator | Agency - State of Oklahoma-EDGE (Economic Development Generating Excellence) |
| Bridging anticoagulation in patients who require temporary interruption of warfarin therapy for an elective invasive procedure or surgery (BRIDGE). | |
| Toni L. Ripley, Pharm.D. - Co-investigator | Agency - Duke University-subcontract for NIH grant U01HL087229 |
| Deaf and Hard of Hearing Poison Prevention Outreach Project | |
| Scott Schaeffer, D.Ph., DABAT - Principal Investigator | Agency - HRSA Poison Center Incentive Grant |
| Real-time surveillance of events associated with nonprescription cough and cold preparations | |
| Scott Shaeffer, DPh, DABAT - Principal Investigator | Agency - Consumer Healthcare Products Assn (CHPA) |
| Host immune response to E. faecalis biofilm | |
| Nathan Shankar, Ph.D. - Principal Investigator | Agency - NIH-NIDCR (R21) |
| Linking Medicare, West Virginia Medicaid, and West Virginia cancer registry data to study the burden of the beast, colorectal, lung and prostate cancers in West Virginia | |
| Michael Smith, Ph.D. - OUHSC PI (subcontractor) | Agency - AHRQ-West Virginia University subcontract |
| How Often Do Catastrophic Injury Victims Become Medicaid Recipients? | |
| Michael J. Smith, Ph.D. - Co-Investigator | Agency - West Virginia University Injury Control Research Center/Centers for Disease Control and Prevention |
| Orphanin FQ regulates tyrosine hydroxylase expression | |
| Kelly Standifer, Ph.D. - Principal Investigator | Agency - OCAST/Regular |
| Blockade of nociceptin signaling reduces biochemical, structural and cognitive deficits after traumatic brain injury | |
| Kelly Standifer, Ph.D. - Principal Investigator | Agency - DoD, Hypothesis Development Award |
| Molecular mechanism of chronic pain and its modulation by post traumatic stress disorder and nociceptin/orphanin FQ | |
| Kelly Standifer, Ph.D. - Principal Investigator | Agency - DoD - US Army (USAMRAA) |
| Targeted delivery and remote-controlled release of chemotherapeutic agents | |
| Youngjae You, Ph.D. - Principal Investigator | Agency - DoD-US Army (USAMRAA) |
| Synthesis and in vitro study to longer-wavelength absorbing photosensitizers targeting cancer cells for PDT (photodynamic therapy) in recurrent breast cancers | |
| Youngjae You, Ph.D. - Principal Investigator | Agency - Peggy and Charles Stephenson Oklahoma Cancer Center Seed Grant |
| New BODIPY-type photosensitizers absorbing near IR light | |
| Youngjae You, Ph.D. - Principal Investigator | Agency - OCAST/Regular |